Tyrer-Cuzick

 

Test description:

Add on TC risk calculation for eligible patients (only available for the following panels: Comprehensive Common Cancer Panel. Common Cancer Management Panel, Breast/Gyn Cancer Panel, BRCA1/2 Sequencing and Del/Dup Analysis, Breast Cancer Management Panel, Pancreatic Cancer Panel, Hereditary Prostate Cancer Panel).

Turnaround Time: TC risk calculation included with test report if selected with the order

Reporting times are typical and begin once the sample(s) are received at the GeneDx laboratory, but could be extended in situations outside GeneDx’s reasonable control.

---

Hereditary Cancer Requisition
Hereditary Cancer Re-requisition